Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration

News   Nov 06, 2012

 
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
 
 
 
 

RELATED ARTICLES

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

NIH links Aldosterone to Alcohol Use Disorder

News

National Institutes of Health study demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute to alcohol use disorder (AUD)

READ MORE

Eye Microbiome Helps Protect Mice From Pathogens

News

Resident microbes living on the eye are essential for immune responses that protect the eye from infection.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE